ARTICLE | Clinical News
AN2728: Phase II started
May 23, 2011 7:00 AM UTC
Anacor began a double-blind, vehicle-controlled, Australian Phase II trial to evaluate topical 1% AN2898 twice daily, 2% AN2728 twice daily and 1% AN2898 plus 2% AN2728 twice daily for 6 weeks in up t...